CompuGroup Medical SE: Release of a capital market information

CompuGroup Medical SE: Disclosure pursuant to Art. 5 Para. 1 lit. b) and Para. 3 of the Regulation (EU) No 596/2014 (MAR) in conjunction with Art. 2 Para. 2 and Para. 3 of the Commission Delegated Regulation (EU) No 2016/1052 - 4th Interim Announcement

CompuGroup Medical SE / Share Buyback

Koblenz, August 13, 2018

CompuGroup Medical SE: Disclosure pursuant to Art. 5 Para. 1 lit. b) and Para. 3 of the Regulation (EU) No 596/2014 (MAR) in conjunction with Art. 2 Para. 2 and Para. 3 of the Commission Delegated Regulation (EU) No 2016/1052 - 4th Interim Announcement

In the period from August 6, 2018, up to and including August 10, 2018, CompuGroup Medical SE has bought back a total of 60,907 shares of CompuGroup Medical SE within the framework of the share buyback program. In the announcement of July 13, 2018, pursuant to Art. 2 para. 1 of the Commission Delegated Regulation (EU) 2016/1052 supplementing Regulation (EU) No 596/2014 (MAR) it was communicated that the repurchase of treasury shares would commence on July 16, 2018.

The overall volume of the shares bought back daily in the period from August 6, 2018, up to and including August 10, 2018, and the daily volumeweighted average stock market prices of the shares are as follows:

The total number of shares which have been bought back so far by CompuGroup Medical SE since July 16, 2018, up to and including August 10, 2018, within the framework of the share buyback program thus amounts to 157,404 no-par value shares.

Further information pursuant to Art. 5 para. 1 lit. b) and para. 3 of the Regulation (EU) No 596/2014 (MAR) in conjunction with Art. 2 para. 2 and para. 3 of the Commission Delegated Regulation (EU) No 2016/1052 is available online under https://www.cgm.com/sbb.

The purchase of the shares of CompuGroup Medical SE was carried out by a bank assigned by CompuGroup Medical SE and exclusively via the Frankfurt Stock Exchange (Xetra trading).

Koblenz, August 13, 2018

The Management Board

CompuGroup Medical SE
Investor Relations
Maria Trost 21
56070 Koblenz, Germany
T: 49 (0) 261 8000-6200
F: 49 (0) 261 8000-3200